This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1988;6(2):167-84.

doi: 10.3109/07357908809077045.

Controversies in the management of febrile neutropenic cancer patients

M Rubin¹, J W Hathorn, P A Pizzo

Affiliations

PMID: 3132310
DOI: 10.3109/07357908809077045

Review

Controversies in the management of febrile neutropenic cancer patients

M Rubin et al. Cancer Invest. 1988.

. 1988;6(2):167-84.

doi: 10.3109/07357908809077045.

Authors

M Rubin¹, J W Hathorn, P A Pizzo

Affiliation

¹ Infectious Disease Section, National Cancer Institute, Bethesda, Maryland 20892.

PMID: 3132310
DOI: 10.3109/07357908809077045

No abstract available

PubMed Disclaimer

Similar articles

Management of fever in granulocytopenic children with cancer.
Katz JA, Mustafa MM. Katz JA, et al. Pediatr Infect Dis J. 1993 Apr;12(4):330-7. doi: 10.1097/00006454-199304000-00013. Pediatr Infect Dis J. 1993. PMID: 8483628 Review. No abstract available.
Management of fever in neutropenic patients.
Bodey GP, Rolston KV. Bodey GP, et al. J Infect Chemother. 2001 Mar;7(1):1-9. doi: 10.1007/s101560170027. J Infect Chemother. 2001. PMID: 11406750 Review.
Neutropenia and fever.
Hughes WT. Hughes WT. Pediatr Infect Dis. 1983 May-Jun;2(3 Suppl):S14-7. Pediatr Infect Dis. 1983. PMID: 6866796 No abstract available.
Current issues in the antibiotic primary management of the febrile neutropenic cancer patient: a perspective from the National Cancer Institute.
Pizzo PA. Pizzo PA. J Hosp Infect. 1990 Apr;15 Suppl A:41-8. doi: 10.1016/0195-6701(90)90078-3. J Hosp Infect. 1990. PMID: 1971644 Clinical Trial.
Drug therapy management of the febrile neutropenic cancer patient.
Finkbiner KL, Ernst TF. Finkbiner KL, et al. Cancer Pract. 1993 Nov-Dec;1(4):295-304. Cancer Pract. 1993. PMID: 8111439 Review.

See all similar articles

Cited by

Risk assessment and risk-based therapy in febrile neutropenic patients.
Rolston KV. Rolston KV. Eur J Clin Microbiol Infect Dis. 1998 Jul;17(7):461-3. doi: 10.1007/BF01691127. Eur J Clin Microbiol Infect Dis. 1998. PMID: 9764547 No abstract available.
Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.
Liang R, Yung R, Chiu E, Chau PY, Chan TK, Lam WK, Todd D. Liang R, et al. Antimicrob Agents Chemother. 1990 Jul;34(7):1336-41. doi: 10.1128/AAC.34.7.1336. Antimicrob Agents Chemother. 1990. PMID: 2201252 Free PMC article. Clinical Trial.
Outpatient antibiotic treatment in low-risk febrile neutropenic cancer patients.
Escalante CP, Rubenstein EB, Rolston KV. Escalante CP, et al. Support Care Cancer. 1996 Sep;4(5):358-63. doi: 10.1007/BF01788842. Support Care Cancer. 1996. PMID: 8883229 Review.
The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
Liang DC. Liang DC. Paediatr Drugs. 2003;5(10):673-84. doi: 10.2165/00148581-200305100-00003. Paediatr Drugs. 2003. PMID: 14510625 Review.
Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination.
de Marie S, van den Broek PJ, Willemze R, van Furth R. de Marie S, et al. Eur J Clin Microbiol Infect Dis. 1993 Dec;12(12):897-906. doi: 10.1007/BF01992162. Eur J Clin Microbiol Infect Dis. 1993. PMID: 8187783 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon